APO Research
Talk to an analyst

APO RESEARCH · REPORT

High Throughput Screening (HTS) Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global High Throughput Screening (HTS) Service Market Outlook and Growth Opportunities 2026

8 January 2026201 pages

Choose your research edition.

Industry ResearchHigh Throughput Screening (HTS) Service Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal High Throughput Screening (HTS) Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal High Throughput Screening (HTS) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal High Throughput Screening (HTS) Service Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal High Throughput Screening (HTS) Service Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global High Throughput Screening (HTS) Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for High Throughput Screening (HTS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for High Throughput Screening (HTS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for High Throughput Screening (HTS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the High Throughput Screening (HTS) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the High Throughput Screening (HTS) Service market include Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences and Bienta (Enamine), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global High Throughput Screening (HTS) Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of High Throughput Screening (HTS) Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents High Throughput Screening (HTS) Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global High Throughput Screening (HTS) Service market.

High Throughput Screening (HTS) Service Segment by Company

Eurofins Discovery

Charles River Laboratories

Axcelead

NUVISAN

Axxam S.p.A.

Evotec

Selvita

Azenta Life Sciences

Bienta (Enamine)

Cayman Chemical

Creative Biolabs

Creative Bioarray

BOC Sciences

MEDICILON

Domainex

Creative Diagnostics

Multispan

AntalGenics

Creative Biostructure

BPS Bioscience

High Throughput Screening (HTS) Service Segment by Type

Chemical-based HTS Service

Biological-based HTS Service

Cell-based HTS Service

Genetic-based HTS Service

High Throughput Screening (HTS) Service Segment by Application

Pharmaceutical Industry

Universities and Scientific Research Institutions

High Throughput Screening (HTS) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global High Throughput Screening (HTS) Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the High Throughput Screening (HTS) Service key companies, revenue, market share, and recent developments.

3. To split the High Throughput Screening (HTS) Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions High Throughput Screening (HTS) Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify High Throughput Screening (HTS) Service significant trends, drivers, influence factors in global and regions.

6. To analyze High Throughput Screening (HTS) Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High Throughput Screening (HTS) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High Throughput Screening (HTS) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High Throughput Screening (HTS) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global High Throughput Screening (HTS) Service industry.

Chapter 3: Detailed analysis of High Throughput Screening (HTS) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of High Throughput Screening (HTS) Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of High Throughput Screening (HTS) Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. High Throughput Screening (HTS) Service Industry Trends Table 2. High Throughput Screening (HTS) Service Industry Drivers Table 3. High Throughput Screening (HTS) Service Industry Opportunities and Challenges Table 4. High Throughput Screening (HTS) Service Industry Restraints Table 5. Global High Throughput Screening (HTS) Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global High Throughput Screening (HTS) Service Revenue Share by Company (2021-2026) Table 7. Global High Throughput Screening (HTS) Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global High Throughput Screening (HTS) Service Key Company Manufacturing Base & Headquarters Table 9. Global High Throughput Screening (HTS) Service Company, Product Type & Application Table 10. Global High Throughput Screening (HTS) Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global High Throughput Screening (HTS) Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chemical-based HTS Service Table 15. Significant Companies of Biological-based HTS Service Table 16. Significant Companies of Cell-based HTS Service Table 17. Significant Companies of Genetic-based HTS Service Table 18. Global High Throughput Screening (HTS) Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global High Throughput Screening (HTS) Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global High Throughput Screening (HTS) Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global High Throughput Screening (HTS) Service Sales Value Share by Type (2021-2026) Table 22. Global High Throughput Screening (HTS) Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Industry Table 24. Significant Companies of Universities and Scientific Research Institutions Table 25. Global High Throughput Screening (HTS) Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global High Throughput Screening (HTS) Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global High Throughput Screening (HTS) Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global High Throughput Screening (HTS) Service Sales Value Share by Application (2021-2026) Table 29. Global High Throughput Screening (HTS) Service Sales Value Share by Application (2027-2032) Table 30. Global High Throughput Screening (HTS) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global High Throughput Screening (HTS) Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global High Throughput Screening (HTS) Service Sales Value Share by Region (2021-2026) Table 33. Global High Throughput Screening (HTS) Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global High Throughput Screening (HTS) Service Sales Value Share by Region (2027-2032) Table 35. Global High Throughput Screening (HTS) Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global High Throughput Screening (HTS) Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global High Throughput Screening (HTS) Service Sales Value Market Share by Country (2021-2026) Table 38. Global High Throughput Screening (HTS) Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global High Throughput Screening (HTS) Service Sales Value Market Share by Country (2027-2032) Table 40. Eurofins Discovery Company Information Table 41. Eurofins Discovery Business Overview Table 42. Eurofins Discovery High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Eurofins Discovery High Throughput Screening (HTS) Service Product Portfolio Table 44. Eurofins Discovery Recent Development Table 45. Charles River Laboratories Company Information Table 46. Charles River Laboratories Business Overview Table 47. Charles River Laboratories High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Charles River Laboratories High Throughput Screening (HTS) Service Product Portfolio Table 49. Charles River Laboratories Recent Development Table 50. Axcelead Company Information Table 51. Axcelead Business Overview Table 52. Axcelead High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Axcelead High Throughput Screening (HTS) Service Product Portfolio Table 54. Axcelead Recent Development Table 55. NUVISAN Company Information Table 56. NUVISAN Business Overview Table 57. NUVISAN High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. NUVISAN High Throughput Screening (HTS) Service Product Portfolio Table 59. NUVISAN Recent Development Table 60. Axxam S.p.A. Company Information Table 61. Axxam S.p.A. Business Overview Table 62. Axxam S.p.A. High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Axxam S.p.A. High Throughput Screening (HTS) Service Product Portfolio Table 64. Axxam S.p.A. Recent Development Table 65. Evotec Company Information Table 66. Evotec Business Overview Table 67. Evotec High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Evotec High Throughput Screening (HTS) Service Product Portfolio Table 69. Evotec Recent Development Table 70. Selvita Company Information Table 71. Selvita Business Overview Table 72. Selvita High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Selvita High Throughput Screening (HTS) Service Product Portfolio Table 74. Selvita Recent Development Table 75. Azenta Life Sciences Company Information Table 76. Azenta Life Sciences Business Overview Table 77. Azenta Life Sciences High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Azenta Life Sciences High Throughput Screening (HTS) Service Product Portfolio Table 79. Azenta Life Sciences Recent Development Table 80. Bienta (Enamine) Company Information Table 81. Bienta (Enamine) Business Overview Table 82. Bienta (Enamine) High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bienta (Enamine) High Throughput Screening (HTS) Service Product Portfolio Table 84. Bienta (Enamine) Recent Development Table 85. Cayman Chemical Company Information Table 86. Cayman Chemical Business Overview Table 87. Cayman Chemical High Throughput Screening (HTS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Cayman Chemical High Throughput Screening (HTS) Service Product Portfolio Table 89. Cayman Chemical Recent Development Table 90. Creative Biolabs Company Information Table 91. Creative Biolabs Business Overview Table 92. Creative Biolabs High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Creative Biolabs High Throughput Screening (HTS) Service Product Portfolio Table 94. Creative Biolabs Recent Development Table 95. Creative Bioarray Company Information Table 96. Creative Bioarray Business Overview Table 97. Creative Bioarray High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Creative Bioarray High Throughput Screening (HTS) Service Product Portfolio Table 99. Creative Bioarray Recent Development Table 100. BOC Sciences Company Information Table 101. BOC Sciences Business Overview Table 102. BOC Sciences High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. BOC Sciences High Throughput Screening (HTS) Service Product Portfolio Table 104. BOC Sciences Recent Development Table 105. MEDICILON Company Information Table 106. MEDICILON Business Overview Table 107. MEDICILON High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. MEDICILON High Throughput Screening (HTS) Service Product Portfolio Table 109. MEDICILON Recent Development Table 110. Domainex Company Information Table 111. Domainex Business Overview Table 112. Domainex High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Domainex High Throughput Screening (HTS) Service Product Portfolio Table 114. Domainex Recent Development Table 115. Creative Diagnostics Company Information Table 116. Creative Diagnostics Business Overview Table 117. Creative Diagnostics High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Creative Diagnostics High Throughput Screening (HTS) Service Product Portfolio Table 119. Creative Diagnostics Recent Development Table 120. Multispan Company Information Table 121. Multispan Business Overview Table 122. Multispan High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Multispan High Throughput Screening (HTS) Service Product Portfolio Table 124. Multispan Recent Development Table 125. AntalGenics Company Information Table 126. AntalGenics Business Overview Table 127. AntalGenics High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. AntalGenics High Throughput Screening (HTS) Service Product Portfolio Table 129. AntalGenics Recent Development Table 130. Creative Biostructure Company Information Table 131. Creative Biostructure Business Overview Table 132. Creative Biostructure High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Creative Biostructure High Throughput Screening (HTS) Service Product Portfolio Table 134. Creative Biostructure Recent Development Table 135. BPS Bioscience Company Information Table 136. BPS Bioscience Business Overview Table 137. BPS Bioscience High Throughput Screening (HTS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. BPS Bioscience High Throughput Screening (HTS) Service Product Portfolio Table 139. BPS Bioscience Recent Development Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. High Throughput Screening (HTS) Service Product Image Figure 2. Global High Throughput Screening (HTS) Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global High Throughput Screening (HTS) Service Market Size (2021-2032) & (US$ Million) Figure 4. Global High Throughput Screening (HTS) Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chemical-based HTS Service Image Figure 8. Biological-based HTS Service Image Figure 9. Cell-based HTS Service Image Figure 10. Genetic-based HTS Service Image Figure 11. Global High Throughput Screening (HTS) Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global High Throughput Screening (HTS) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global High Throughput Screening (HTS) Service Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Industry Image Figure 15. Universities and Scientific Research Institutions Image Figure 16. Global High Throughput Screening (HTS) Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global High Throughput Screening (HTS) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global High Throughput Screening (HTS) Service Sales Value Share by Application (2021-2032) Figure 19. Global High Throughput Screening (HTS) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global High Throughput Screening (HTS) Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America High Throughput Screening (HTS) Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America High Throughput Screening (HTS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe High Throughput Screening (HTS) Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe High Throughput Screening (HTS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific High Throughput Screening (HTS) Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific High Throughput Screening (HTS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America High Throughput Screening (HTS) Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America High Throughput Screening (HTS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa High Throughput Screening (HTS) Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa High Throughput Screening (HTS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical-based HTS Service
  • Biological-based HTS Service
  • Cell-based HTS Service
  • Genetic-based HTS Service
Applications
  • Pharmaceutical Industry
  • Universities and Scientific Research Institutions
Companies covered
  • Eurofins Discovery
  • Charles River Laboratories
  • Axcelead
  • NUVISAN
  • Axxam S.p.A.
  • Evotec
  • Selvita
  • Azenta Life Sciences
  • Bienta (Enamine)
  • Cayman Chemical
  • Creative Biolabs
  • Creative Bioarray
  • BOC Sciences
  • MEDICILON
  • Domainex
  • Creative Diagnostics
  • Multispan
  • AntalGenics
  • Creative Biostructure
  • BPS Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global High Throughput Screening (HTS) Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global High Throughput Screening (HTS) Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 High Throughput Screening (HTS) Service Market Dynamics
  1. 2.1 High Throughput Screening (HTS) Service Industry Trends
  2. 2.2 High Throughput Screening (HTS) Service Industry Drivers
  3. 2.3 High Throughput Screening (HTS) Service Industry Opportunities and Challenges
  4. 2.4 High Throughput Screening (HTS) Service Industry Restraints
3 High Throughput Screening (HTS) Service Market by Company
  1. 3.1 Global High Throughput Screening (HTS) Service Company Revenue Ranking in 2025
  2. 3.2 Global High Throughput Screening (HTS) Service Revenue by Company (2021-2026)
  3. 3.3 Global High Throughput Screening (HTS) Service Company Ranking (2024-2026)
  4. 3.4 Global High Throughput Screening (HTS) Service Company Manufacturing Base and Headquarters
  5. 3.5 Global High Throughput Screening (HTS) Service Company Product Type and Application
  6. 3.6 Global High Throughput Screening (HTS) Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global High Throughput Screening (HTS) Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 High Throughput Screening (HTS) Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 High Throughput Screening (HTS) Service Market by Type
  1. 4.1 High Throughput Screening (HTS) Service Type Introduction
  2. 4.1.1 Chemical-based HTS Service
  3. 4.1.2 Biological-based HTS Service
  4. 4.1.3 Cell-based HTS Service
  5. 4.1.4 Genetic-based HTS Service
  6. 4.2 Global High Throughput Screening (HTS) Service Sales Value by Type
  7. 4.2.1 Global High Throughput Screening (HTS) Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global High Throughput Screening (HTS) Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global High Throughput Screening (HTS) Service Sales Value Share by Type (2021-2032)
5 High Throughput Screening (HTS) Service Market by Application
  1. 5.1 High Throughput Screening (HTS) Service Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 Universities and Scientific Research Institutions
  4. 5.2 Global High Throughput Screening (HTS) Service Sales Value by Application
  5. 5.2.1 Global High Throughput Screening (HTS) Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global High Throughput Screening (HTS) Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global High Throughput Screening (HTS) Service Sales Value Share by Application (2021-2032)
6 High Throughput Screening (HTS) Service Regional Value Analysis
  1. 6.1 Global High Throughput Screening (HTS) Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global High Throughput Screening (HTS) Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global High Throughput Screening (HTS) Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global High Throughput Screening (HTS) Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America High Throughput Screening (HTS) Service Sales Value (2021-2032)
  7. 6.3.2 North America High Throughput Screening (HTS) Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe High Throughput Screening (HTS) Service Sales Value (2021-2032)
  10. 6.4.2 Europe High Throughput Screening (HTS) Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific High Throughput Screening (HTS) Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific High Throughput Screening (HTS) Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America High Throughput Screening (HTS) Service Sales Value (2021-2032)
  16. 6.6.2 South America High Throughput Screening (HTS) Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa High Throughput Screening (HTS) Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa High Throughput Screening (HTS) Service Sales Value Share by Country, 2025 VS 2032
7 High Throughput Screening (HTS) Service Country-level Value Analysis
  1. 7.1 Global High Throughput Screening (HTS) Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global High Throughput Screening (HTS) Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global High Throughput Screening (HTS) Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global High Throughput Screening (HTS) Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt High Throughput Screening (HTS) Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt High Throughput Screening (HTS) Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt High Throughput Screening (HTS) Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Discovery
  2. 8.1.1 Eurofins Discovery Company Information
  3. 8.1.2 Eurofins Discovery Business Overview
  4. 8.1.3 Eurofins Discovery High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Discovery High Throughput Screening (HTS) Service Product Portfolio
  6. 8.1.5 Eurofins Discovery Recent Developments
  7. 8.2 Charles River Laboratories
  8. 8.2.1 Charles River Laboratories Company Information
  9. 8.2.2 Charles River Laboratories Business Overview
  10. 8.2.3 Charles River Laboratories High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Laboratories High Throughput Screening (HTS) Service Product Portfolio
  12. 8.2.5 Charles River Laboratories Recent Developments
  13. 8.3 Axcelead
  14. 8.3.1 Axcelead Company Information
  15. 8.3.2 Axcelead Business Overview
  16. 8.3.3 Axcelead High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Axcelead High Throughput Screening (HTS) Service Product Portfolio
  18. 8.3.5 Axcelead Recent Developments
  19. 8.4 NUVISAN
  20. 8.4.1 NUVISAN Company Information
  21. 8.4.2 NUVISAN Business Overview
  22. 8.4.3 NUVISAN High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NUVISAN High Throughput Screening (HTS) Service Product Portfolio
  24. 8.4.5 NUVISAN Recent Developments
  25. 8.5 Axxam S.p.A.
  26. 8.5.1 Axxam S.p.A. Company Information
  27. 8.5.2 Axxam S.p.A. Business Overview
  28. 8.5.3 Axxam S.p.A. High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Axxam S.p.A. High Throughput Screening (HTS) Service Product Portfolio
  30. 8.5.5 Axxam S.p.A. Recent Developments
  31. 8.6 Evotec
  32. 8.6.1 Evotec Company Information
  33. 8.6.2 Evotec Business Overview
  34. 8.6.3 Evotec High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evotec High Throughput Screening (HTS) Service Product Portfolio
  36. 8.6.5 Evotec Recent Developments
  37. 8.7 Selvita
  38. 8.7.1 Selvita Company Information
  39. 8.7.2 Selvita Business Overview
  40. 8.7.3 Selvita High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Selvita High Throughput Screening (HTS) Service Product Portfolio
  42. 8.7.5 Selvita Recent Developments
  43. 8.8 Azenta Life Sciences
  44. 8.8.1 Azenta Life Sciences Company Information
  45. 8.8.2 Azenta Life Sciences Business Overview
  46. 8.8.3 Azenta Life Sciences High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Azenta Life Sciences High Throughput Screening (HTS) Service Product Portfolio
  48. 8.8.5 Azenta Life Sciences Recent Developments
  49. 8.9 Bienta (Enamine)
  50. 8.9.1 Bienta (Enamine) Company Information
  51. 8.9.2 Bienta (Enamine) Business Overview
  52. 8.9.3 Bienta (Enamine) High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bienta (Enamine) High Throughput Screening (HTS) Service Product Portfolio
  54. 8.9.5 Bienta (Enamine) Recent Developments
  55. 8.10 Cayman Chemical
  56. 8.10.1 Cayman Chemical Company Information
  57. 8.10.2 Cayman Chemical Business Overview
  58. 8.10.3 Cayman Chemical High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cayman Chemical High Throughput Screening (HTS) Service Product Portfolio
  60. 8.10.5 Cayman Chemical Recent Developments
  61. 8.11 Creative Biolabs
  62. 8.11.1 Creative Biolabs Company Information
  63. 8.11.2 Creative Biolabs Business Overview
  64. 8.11.3 Creative Biolabs High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Creative Biolabs High Throughput Screening (HTS) Service Product Portfolio
  66. 8.11.5 Creative Biolabs Recent Developments
  67. 8.12 Creative Bioarray
  68. 8.12.1 Creative Bioarray Company Information
  69. 8.12.2 Creative Bioarray Business Overview
  70. 8.12.3 Creative Bioarray High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Creative Bioarray High Throughput Screening (HTS) Service Product Portfolio
  72. 8.12.5 Creative Bioarray Recent Developments
  73. 8.13 BOC Sciences
  74. 8.13.1 BOC Sciences Company Information
  75. 8.13.2 BOC Sciences Business Overview
  76. 8.13.3 BOC Sciences High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BOC Sciences High Throughput Screening (HTS) Service Product Portfolio
  78. 8.13.5 BOC Sciences Recent Developments
  79. 8.14 MEDICILON
  80. 8.14.1 MEDICILON Company Information
  81. 8.14.2 MEDICILON Business Overview
  82. 8.14.3 MEDICILON High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MEDICILON High Throughput Screening (HTS) Service Product Portfolio
  84. 8.14.5 MEDICILON Recent Developments
  85. 8.15 Domainex
  86. 8.15.1 Domainex Company Information
  87. 8.15.2 Domainex Business Overview
  88. 8.15.3 Domainex High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Domainex High Throughput Screening (HTS) Service Product Portfolio
  90. 8.15.5 Domainex Recent Developments
  91. 8.16 Creative Diagnostics
  92. 8.16.1 Creative Diagnostics Company Information
  93. 8.16.2 Creative Diagnostics Business Overview
  94. 8.16.3 Creative Diagnostics High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Creative Diagnostics High Throughput Screening (HTS) Service Product Portfolio
  96. 8.16.5 Creative Diagnostics Recent Developments
  97. 8.17 Multispan
  98. 8.17.1 Multispan Company Information
  99. 8.17.2 Multispan Business Overview
  100. 8.17.3 Multispan High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Multispan High Throughput Screening (HTS) Service Product Portfolio
  102. 8.17.5 Multispan Recent Developments
  103. 8.18 AntalGenics
  104. 8.18.1 AntalGenics Company Information
  105. 8.18.2 AntalGenics Business Overview
  106. 8.18.3 AntalGenics High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 AntalGenics High Throughput Screening (HTS) Service Product Portfolio
  108. 8.18.5 AntalGenics Recent Developments
  109. 8.19 Creative Biostructure
  110. 8.19.1 Creative Biostructure Company Information
  111. 8.19.2 Creative Biostructure Business Overview
  112. 8.19.3 Creative Biostructure High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Creative Biostructure High Throughput Screening (HTS) Service Product Portfolio
  114. 8.19.5 Creative Biostructure Recent Developments
  115. 8.20 BPS Bioscience
  116. 8.20.1 BPS Bioscience Company Information
  117. 8.20.2 BPS Bioscience Business Overview
  118. 8.20.3 BPS Bioscience High Throughput Screening (HTS) Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 BPS Bioscience High Throughput Screening (HTS) Service Product Portfolio
  120. 8.20.5 BPS Bioscience Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst